PYRATZ CORP. (ENXTPA: MLPTZ)
Health Care · Pharmaceuticals · FR
€0.06
+13.76% today · -31.1% 1Y
PYRATZ CORP. (ENXTPA: MLPTZ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $21.41M.
Over the last twelve months the share price has lost 31.1%, trading between 0.05 and 0.09.
MLPTZ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.41M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- €0.09
- 52-week low
- €0.05
- Avg volume (3M)
- —
- Shares outstanding
- 298.32M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.81 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.49 | +0.46% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.48 | -0.05% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.90 | -1.52% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.80 | -1.31% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.